Somite Therapeutics and OmniaBio Collaborate to Advance AI-Driven Cell Therapy for Duchenne Muscular Dystrophy
Somite Therapeutics, a tech-bio company focused on AI-powered cell therapies, has announced a partnership with OmniaBio Inc., a global cell and gene therapy CDMO. The collaboration aims to advance Somite’s flagship program,...
Read More